We are live on ! Find out more
HBW

Hazlett, Burt & Watson Portfolio holdings

AUM $320M
1-Year Est. Return 24.67%
This Fund
S&P 500
This Quarter Est. Return
+10.21%
1 Year Est. Return
+24.67%
3 Year Est. Return
+69.22%
5 Year Est. Return
10 Year Est. Return
AUM
$114M
AUM Growth
+$10.5M
Cap. Flow
+$1.42M
Cap. Flow %
1.25%
Top 10 Hldgs %
33.23%
Holding
657
New
24
Increased
190
Reduced
86
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 15.35%
2 Financials 10.58%
3 Healthcare 10.11%
4 Consumer Staples 7.06%
5 Industrials 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMRD
651
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$0 ﹤0.01%
30
DBD
652
DELISTED
Diebold Nixdorf Incorporated
DBD
$0 ﹤0.01%
200
ARVL
653
DELISTED
Arrival Ordinary Shares
ARVL
$0 ﹤0.01%
3
AERI
654
DELISTED
Aerie Pharmaceuticals
AERI
-22,200
Closed -$338K
TWTR
655
DELISTED
Twitter, Inc.
TWTR
-350
Closed -$16K
CVET
656
DELISTED
Covetrus, Inc. Common Stock
CVET
-760
Closed -$17K
ATVI
657
DELISTED
Activision Blizzard
ATVI
-257
Closed -$19.1K

Similar funds

Hazlett, Burt & Watson's Q4 2022 Portfolio in Review

As of Q4 2022, Hazlett, Burt & Watson held 657 positions worth $114M, up 10% from $103M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Hazlett, Burt & Watson's Q4 2022 filing shows 24 new, 190 increased, 86 reduced and 23 closed positions. Its largest new stake was United Therapeutics: 200 shares worth $56K. The largest sale was ExxonMobil, an estimated $806K.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Hazlett, Burt & Watson's largest Q4 2022 buy was United Therapeutics: 200 shares worth $56K.
  • Hazlett, Burt & Watson added most to Schwab US Dividend Equity ETF in Q4 2022, an estimated $1.34M increase.
  • Hazlett, Burt & Watson's biggest Q4 2022 reduction was ExxonMobil, cutting an estimated $806K.
  • Hazlett, Burt & Watson fully exited Aerie Pharmaceuticals in Q4 2022, selling an estimated $338K.
  • Hazlett, Burt & Watson's ten largest holdings make up 33% of its $114M portfolio in Q4 2022.
  • Hazlett, Burt & Watson opened 24 new positions and closed 23 in Q4 2022.
  • Hazlett, Burt & Watson's portfolio value rose 10% quarter-over-quarter to $114M.

Based on Hazlett, Burt & Watson's 13F filing for Q4 2022, filed 25 Jan 2023.